INTERNATIONAL PATENT: PFIZER INC., CTXT PTY LTD FILES APPLICATION FOR "CRYSTALLINE FORM OF 2-METHOXY-N-{4-METHOXY-6-[(1H-PYRAZOL-1-YL)METHYL]-1,2-BENZOXAZOL-3-YL}BENZENE-1-SULFONAMIDE"

GENEVA, July 8 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192), CTXT PTY LTD (305 Grattan StreetMelbourne, Victoria 3000) filed a patent application (PCT/IB2024/063136) for "CRYSTALLINE FORM OF 2-METHOXY-N-{4-METHOXY-6-[(1H-PYRAZOL-1-YL)METHYL]-1,2-BENZOXAZOL-3-YL}BENZENE-1-SULFONAMIDE" on Dec 23, 2024. With publication no. WO/2025/141469, the details related to the patent application was published on Jul 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HILLS, Andrew Kevern (c/o Pfizer R&D UK LimitedRamsgate RoadSandwich, Kent CT13 9NJ)

Abstract: The invention re...